171 related articles for article (PubMed ID: 32998396)
21. Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma.
Li J; Li Y; Wu X; Li Y
Oncol Lett; 2019 Jun; 17(6):5642-5652. PubMed ID: 31186787
[TBL] [Abstract][Full Text] [Related]
22. EGOT lncRNA in head and neck squamous cell carcinomas.
Kolenda T; Kopczyńska M; Guglas K; Teresiak A; Bliźniak R; Łasińska I; Mackiewicz J; Lamperska K
Pol J Pathol; 2018; 69(4):356-365. PubMed ID: 30786685
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J
Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995
[No Abstract] [Full Text] [Related]
24. Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy.
Gameiro SF; Ghasemi F; Barrett JW; Koropatnick J; Nichols AC; Mymryk JS; Maleki Vareki S
Oncoimmunology; 2018; 7(10):e1498439. PubMed ID: 30288365
[TBL] [Abstract][Full Text] [Related]
25. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
27. Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Prusinkiewicz MA; Gameiro SF; Ghasemi F; Dodge MJ; Zeng PYF; Maekebay H; Barrett JW; Nichols AC; Mymryk JS
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968678
[TBL] [Abstract][Full Text] [Related]
28. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Gameiro SF; Ghasemi F; Zeng PYF; Mundi N; Howlett CJ; Plantinga P; Barrett JW; Nichols AC; Mymryk JS
Infect Agent Cancer; 2021 Feb; 16(1):13. PubMed ID: 33588906
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
30. The Oncogenic Roles of
Grzechowiak I; Graś J; Szymańska D; Biernacka M; Guglas K; Poter P; Mackiewicz A; Kolenda T
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32824814
[TBL] [Abstract][Full Text] [Related]
31. The Impact of YRNAs on HNSCC and HPV Infection.
Guglas K; Kolenda T; Kozłowska-Masłoń J; Severino P; Teresiak A; Bliźniak R; Lamperska K
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979661
[TBL] [Abstract][Full Text] [Related]
32. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma.
Alsbeih G; Al-Harbi N; Bin Judia S; Al-Qahtani W; Khoja H; El-Sebaie M; Tulbah A
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200489
[TBL] [Abstract][Full Text] [Related]
34. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
35. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of HNSCC with or without HPV infection.
Zhou D; Wang J; Wang J; Liu X
Am J Transl Res; 2021; 13(4):2163-2180. PubMed ID: 34017381
[TBL] [Abstract][Full Text] [Related]
36. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
[TBL] [Abstract][Full Text] [Related]
37. HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.
Firmino N; Martinez VD; Rowbotham DA; Enfield KSS; Bennewith KL; Lam WL
Oral Oncol; 2016 Apr; 55():43-48. PubMed ID: 26852287
[TBL] [Abstract][Full Text] [Related]
38. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
39. Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck.
Łasińska I; Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Strzelecki NO; Lamperska K; Mackiewicz A; Mackiewicz J
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32947877
[No Abstract] [Full Text] [Related]
40. HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients.
Rivera-Peña B; Ruíz-Fullana FJ; Vélez-Reyes GL; Rodriguez-Benitez RJ; Marcos-Martínez MJ; Trinidad-Pinedo J; Báez A
Infect Agent Cancer; 2016; 11(1):47. PubMed ID: 27559359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
